| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.08▲ | 3.06▲ | 3.05▲ | 3.10▼ | 2.88▲ |
| MA10 | 3.08▲ | 3.04▲ | 3.03▲ | 3.01▲ | 2.90▲ |
| MA20 | 3.06▲ | 3.03▲ | 3.07▲ | 2.85▲ | 3.12▼ |
| MA50 | 3.03▲ | 3.09▲ | 3.07▲ | 2.89▲ | 3.77▼ |
| MA100 | 3.02▲ | 3.05▲ | 2.96▲ | 3.28▼ | 5.06▼ |
| MA200 | 3.05▲ | 2.94▲ | 2.88▲ | 3.85▼ | 6.33▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.014▲ | 0.004▲ | 0.038▲ | 0.045▲ |
| RSI | 68.760▲ | 59.039▲ | 54.317▲ | 59.099▲ | 45.706▼ |
| STOCH | 65.257 | 78.590 | 75.421 | 59.456 | 33.925 |
| WILL %R | -15.385▲ | -5.556▲ | -10.526▲ | -38.462 | -50.000 |
| CCI | 145.600▲ | 195.469▲ | 249.458▲ | 46.161 | 45.863 |
|
Sunday, July 05, 2026 03:08 PM
Altimmune, Inc. (NASDAQ:ALT), backed by significant analyst-implied upside, ranks among the overlooked penny stocks to buy right now.
|
|
Wednesday, June 24, 2026 06:26 AM
TheFly reported on May 18 that H.C. Wainwright reiterated its Buy rating on ALT while reducing its price objective from $25 to $20.
|
|
Wednesday, June 17, 2026 08:40 AM
Altimmune, Inc. (NASDAQ:ALT) is one of the small-cap stocks with potential to rise 1000 percent. The company’s lead drug candidate, pemvidutide, is being developed for MASH, a serious liver disease ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/07/26 | 2.93 | 3.11 | 2.93 | 3.10 | 2,868,332 |
| 07/07/26 | 3.08 | 3.12 | 2.96 | 3.02 | 4,553,694 |
| 06/07/26 | 3.25 | 3.30 | 3.08 | 3.08 | 4,286,307 |
| 02/07/26 | 3.18 | 3.2595 | 3.10 | 3.16 | 4,014,010 |
| 01/07/26 | 3.02 | 3.40 | 3.00 | 3.15 | 7,961,079 |
| 30/06/26 | 2.95 | 3.14 | 2.914 | 3.04 | 4,328,822 |
| 29/06/26 | 2.85 | 2.94 | 2.79 | 2.94 | 3,578,741 |
| 26/06/26 | 2.85 | 2.904 | 2.745 | 2.82 | 13,120,564 |
| 25/06/26 | 2.96 | 2.995 | 2.86 | 2.87 | 2,752,755 |
| 24/06/26 | 2.92 | 3.04 | 2.92 | 2.95 | 3,101,035 |
|
|
||||
|
|
||||
|
|